Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center

被引：15

作者：

Stephens, D. M. ^{[1
,2
]}

Ruppert, A. S. ^{[2
]}

Jones, J. A. ^{[1
,2
]}

Woyach, J. ^{[1
,2
]}

Maddocks, K. ^{[1
,2
]}

Jaglowski, S. M. ^{[1
,2
]}

Andritsos, L. A. ^{[1
,2
]}

Flynn, J. M. ^{[1
,2
]}

Grever, M. R. ^{[1
]}

Lozanski, G. ^{[4
]}

Johnson, A. J. ^{[1
,2
,5
]}

Muthusamy, N. ^{[1
,2
]}

Heerema, N. A. ^{[2
,3
]}

Byrd, J. C. ^{[1
,2
,5
]}

机构：

[1] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA

[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[3] Ohio State Univ, Dept Pathol, Cytogenet Div, Columbus, OH 43210 USA

[4] Ohio State Univ, Dept Pathol, Div Hematopathol, Columbus, OH 43210 USA

[5] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA

来源：

LEUKEMIA | 2014年 / 28卷 / 06期

关键词：

P53; FLAVOPIRIDOL;

D O I：

10.1038/leu.2014.42

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1365 / 1368

页数：5

共 15 条

[1] Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol [J].

Blum, K. A. ;

Ruppert, A. S. ;

Woyach, J. A. ;

Jones, J. A. ;

Andritsos, L. ;

Flynn, J. M. ;

Rovin, B. ;

Villalona-Calero, M. ;

Ji, J. ;

Phelps, M. ;

Johnson, A. J. ;

Grever, M. R. ;

Byrd, J. C. .

LEUKEMIA, 2011, 25 (09) :1444-1451

[2] Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia [J].

Byrd, John C. ;

Lin, Thomas S. ;

Dalton, James T. ;

Wu, Di ;

Phelps, Mitch A. ;

Fischer, Beth ;

Moran, Mollie ;

Blum, Kristie A. ;

Rovin, Brad ;

Brooker-McEldowney, Michelle ;

Broering, Sarah ;

Schaaf, Larry J. ;

Johnson, Amy J. ;

Lucas, David M. ;

Heerema, Nyla A. ;

Lozanski, Gerard ;

Young, Donn C. ;

Suarez, Jose-Ramon ;

Colevas, A. Dimitrios ;

Grever, Michael R. .

BLOOD, 2007, 109 (02) :399-404

[3] Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia [J].

Byrd, John C. ;

Furman, Richard R. ;

Coutre, Steven E. ;

Flinn, Ian W. ;

Burger, Jan A. ;

Blum, Kristie A. ;

Grant, Barbara ;

Sharman, Jeff P. ;

Coleman, Morton ;

Wierda, William G. ;

Jones, Jeffrey A. ;

Zhao, Weiqiang ;

Heerema, Nyla A. ;

Johnson, Amy J. ;

Sukbuntherng, Juthamas ;

Chang, Betty Y. ;

Clow, Fong ;

Hedrick, Eric ;

Buggy, Joseph J. ;

James, Danelle F. ;

O'Brien, Susan .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) :32-42

[4] Genomic aberrations and survival in chronic lymphocytic leukemia. [J].

Döhner, H ;

Stilgenbauer, S ;

Benner, A ;

Leupolt, E ;

Kröber, A ;

Bullinger, L ;

Döhner, K ;

Bentz, M ;

Lichter, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916

[5] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[6] Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study [J].

Heerema, Nyla A. ;

Byrd, John C. ;

Dal Cin, Paola S. ;

Aquila, Marie L. Dell' ;

Koduru, Prasad R. K. ;

Aviram, Ayala ;

Smoley, Stephanie A. ;

Rassenti, Laura Z. ;

Greaves, Andrew W. ;

Brown, Jennifer R. ;

Rai, Kanti R. ;

Kipps, Thomas J. ;

Kay, Neil E. ;

Van Dyke, Daniel L. .

CANCER GENETICS AND CYTOGENETICS, 2010, 203 (02) :134-140

[7] LOCALIZATION OF GENE FOR HUMAN P53 TUMOR-ANTIGEN TO BAND 17P13 [J].

ISOBE, M ;

EMANUEL, BS ;

GIVOL, D ;

OREN, M ;

CROCE, CM .

NATURE, 1986, 320 (6057) :84-85

[8] p53, the cellular gatekeeper for growth and division [J].

Levine, AJ .

CELL, 1997, 88 (03) :323-331

[9] Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease [J].

Lin, Thomas S. ;

Ruppert, Amy S. ;

Johnson, Amy J. ;

Fischer, Beth ;

Heerema, Nyla A. ;

Andritsos, Leslie A. ;

Blum, Kristie A. ;

Flynn, Joseph M. ;

Jones, Jeffrey A. ;

Hu, Weihong ;

Moran, Mollie E. ;

Mitchell, Sarah M. ;

Smith, Lisa L. ;

Wagner, Amy J. ;

Raymond, Chelsey A. ;

Schaaf, Larry J. ;

Phelps, Mitch A. ;

Villalona-Calero, Miguel A. ;

Grever, Michael R. ;

Byrd, John C. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :6012-6018

[10] Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate [J].

Muthusamy, Natarajan ;

Breidenbach, Heather ;

Andritsos, Leslie ;

Flynn, Joseph ;

Jones, Jeffrey ;

Ramanunni, Asha ;

Mo, Xiaokui ;

Jarjoura, David ;

Byrd, John C. ;

Heerema, Nyla A. .

CANCER GENETICS, 2011, 204 (02) :77-83

← 1 2 →